Quick Answer
EXOZYMES INC. reported Stockholders Equity of $3.40 million for fiscal year 2025.
EXOZYMES INC. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $3.40M | -67.4% |
| 2024 | $10.42M | +2811.5% |
| 2023 | -$384.3K | -128.0% |
| 2022 | $1.37M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.37M | +249.2% | -25.7% |
| June 30, 2025 | $7.24M | +419.8% | -18.5% |
| March 31, 2025 | $8.88M | +810.5% | -14.8% |
| December 31, 2024 | $10.42M | +2811.5% | +389.4% |
| September 30, 2024 | -$3.60M | -693.2% | -59.2% |
| June 30, 2024 | -$2.26M | -312.1% | -81.0% |
| March 31, 2024 | -$1.25M | -205.4% | -225.2% |
| December 31, 2023 | -$384.3K | -128.0% | -163.3% |
- EXOZYMES INC. showed a decrease of -67.4% in Stockholders Equity compared to the prior fiscal year.
- Over the 2022–2025 period, EXOZYMES INC.’s stockholders equity has grown by 147.5% (from $1.37 million to $3.40 million).
- The most recent figure is from EXOZYMES INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: